サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1777161

性感染症（STD）治療の世界市場 2025年～2029年

Global Sexually Transmitted Diseases (STD) Treatment Market 2025-2029

出版日
発行
TechNavio
ページ情報
英文 220 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
性感染症（STD）治療の世界市場 2025年～2029年
出版日: 2025年07月17日
発行: TechNavio
ページ情報: 英文 220 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

性感染症（STD）治療市場は2024年から2029年に242億520万米ドルとなり、予測期間中のCAGRは7％で成長すると予測されます。

当レポートでは、性感染症（STD）治療市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、STDの有病率の増加、STDに対する有利な償還政策治療範囲の存在、および世界各国政府によるイニシアチブの増加によって牽引されています。

市場範囲
基準年 2025年
終了年 2029年
予測期間 2025年～2029年
成長モメンタム 加速
前年比 6.5%
CAGR 7%
増分額 242億520万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには実績データと予測データがあります。

本調査では、今後数年間の性感染症（STD）治療市場の成長を促進する主な要因の一つとして、STDの迅速診断の進歩を挙げています。また、STDに関する認知度を高めるための様々な組織の関与の増加や、eptの採用拡大が市場の大きな需要につながると考えられています。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavio分析

  • 価格感度・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模、2024年
  • 市場の見通し、2024年～2029年

第5章 市場規模実績

  • 性感染症（STD）治療の世界市場、2019年～2023年
  • タイプセグメント分析、2019年～2023年
  • 投与経路セグメント分析、2019年～2023年
  • エンドユーザーセグメント分析、2019年～2023年
  • 地域別セグメント分析、2019年～2023年
  • 国別セグメント分析、2019年～2023年

第6章 定性分析

  • AIの影響：性感染症（STD）治療の世界市場

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場セグメンテーション：タイプ別

  • 市場セグメント
  • 比較：タイプ別
  • ウイルス感染：市場規模と予測、2024年～2029年
  • 細菌感染症：市場規模と予測、2024年～2029年
  • その他：市場規模と予測、2024年～2029年
  • 市場機会：タイプ別

第9章 市場セグメンテーション：投与経路別

  • 市場セグメント
  • 比較：投与経路別
  • 経口：市場規模と予測、2024年～2029年
  • 外用剤トピック：市場規模と予測、2024年～2029年
  • 注射剤：市場規模と予測、2024年～2029年
  • 市場機会：投与経路別

第10章 市場セグメンテーション：エンドユーザー別

  • 市場セグメント
  • 比較：エンドユーザー別
  • 病院と診療所：市場規模と予測、2024年～2029年
  • 診断センター：市場規模と予測、2024年～2029年
  • 個人：市場規模と予測、2024年～2029年
  • 市場機会：エンドユーザー別

第11章 顧客情勢

  • 顧客情勢の概要

第12章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米：市場規模と予測、2024年～2029年
  • 欧州：市場規模と予測、2024年～2029年
  • アジア：市場規模と予測、2024年～2029年
  • 世界のその他の地域：市場規模と予測、2024年～2029年
  • 米国：市場規模と予測、2024年～2029年
  • 中国：市場規模と予測、2024年～2029年
  • ドイツ：市場規模と予測、2024年～2029年
  • カナダ：市場規模と予測、2024年～2029年
  • 英国：市場規模と予測、2024年～2029年
  • フランス：市場規模と予測、2024年～2029年
  • インド：市場規模と予測、2024年～2029年
  • イタリア：市場規模と予測、2024年～2029年
  • 日本：市場規模と予測、2024年～2029年
  • スペイン：市場規模と予測、2024年～2029年
  • 市場機会：地域情勢別

第13章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第14章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第15章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • Aurobindo Pharma Ltd.
  • Becton Dickinson and Co.
  • Cepheid Inc.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • Hologic Inc.
  • Inovio Pharmaceuticals Inc.
  • Johnson and Johnson Services Inc.
  • Lupin Ltd.
  • Merck and Co. Inc.
  • Mission Pharmacal Co.
  • Mylan
  • Thermo Fisher Scientific Inc.

第16章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibits7: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits8: Executive Summary - Chart on Incremental Growth
  • Exhibits9: Executive Summary - Data Table on Incremental Growth
  • Exhibits10: Executive Summary - Chart on Company Market Positioning
  • Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits12: Overview on criticality of inputs and factors of differentiation
  • Exhibits13: Overview on factors of disruption
  • Exhibits14: Impact of drivers and challenges in 2024 and 2029
  • Exhibits15: Parent Market
  • Exhibits16: Data Table on - Parent Market
  • Exhibits17: Market characteristics analysis
  • Exhibits18: Value chain analysis
  • Exhibits19: Offerings of companies included in the market definition
  • Exhibits20: Market segments
  • Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits25: Historic Market Size - Data Table on Global Sexually Transmitted Diseases (STD) Treatment Market 2019 - 2023 ($ million)
  • Exhibits26: Historic Market Size - Type Segment 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits31: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits37: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits38: Chart on Type - Market share 2024-2029 (%)
  • Exhibits39: Data Table on Type - Market share 2024-2029 (%)
  • Exhibits40: Chart on Comparison by Type
  • Exhibits41: Data Table on Comparison by Type
  • Exhibits42: Chart on Viral infections - Market size and forecast 2024-2029 ($ million)
  • Exhibits43: Data Table on Viral infections - Market size and forecast 2024-2029 ($ million)
  • Exhibits44: Chart on Viral infections - Year-over-year growth 2024-2029 (%)
  • Exhibits45: Data Table on Viral infections - Year-over-year growth 2024-2029 (%)
  • Exhibits46: Chart on Bacterial infections - Market size and forecast 2024-2029 ($ million)
  • Exhibits47: Data Table on Bacterial infections - Market size and forecast 2024-2029 ($ million)
  • Exhibits48: Chart on Bacterial infections - Year-over-year growth 2024-2029 (%)
  • Exhibits49: Data Table on Bacterial infections - Year-over-year growth 2024-2029 (%)
  • Exhibits50: Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits51: Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits52: Chart on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits53: Data Table on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits54: Market opportunity by Type ($ million)
  • Exhibits55: Data Table on Market opportunity by Type ($ million)
  • Exhibits56: Chart on Route of Administration - Market share 2024-2029 (%)
  • Exhibits57: Data Table on Route of Administration - Market share 2024-2029 (%)
  • Exhibits58: Chart on Comparison by Route of Administration
  • Exhibits59: Data Table on Comparison by Route of Administration
  • Exhibits60: Chart on Oral - Market size and forecast 2024-2029 ($ million)
  • Exhibits61: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
  • Exhibits62: Chart on Oral - Year-over-year growth 2024-2029 (%)
  • Exhibits63: Data Table on Oral - Year-over-year growth 2024-2029 (%)
  • Exhibits64: Chart on Topical - Market size and forecast 2024-2029 ($ million)
  • Exhibits65: Data Table on Topical - Market size and forecast 2024-2029 ($ million)
  • Exhibits66: Chart on Topical - Year-over-year growth 2024-2029 (%)
  • Exhibits67: Data Table on Topical - Year-over-year growth 2024-2029 (%)
  • Exhibits68: Chart on Injectable - Market size and forecast 2024-2029 ($ million)
  • Exhibits69: Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
  • Exhibits70: Chart on Injectable - Year-over-year growth 2024-2029 (%)
  • Exhibits71: Data Table on Injectable - Year-over-year growth 2024-2029 (%)
  • Exhibits72: Market opportunity by Route of Administration ($ million)
  • Exhibits73: Data Table on Market opportunity by Route of Administration ($ million)
  • Exhibits74: Chart on End-user - Market share 2024-2029 (%)
  • Exhibits75: Data Table on End-user - Market share 2024-2029 (%)
  • Exhibits76: Chart on Comparison by End-user
  • Exhibits77: Data Table on Comparison by End-user
  • Exhibits78: Chart on Hospital and clinics - Market size and forecast 2024-2029 ($ million)
  • Exhibits79: Data Table on Hospital and clinics - Market size and forecast 2024-2029 ($ million)
  • Exhibits80: Chart on Hospital and clinics - Year-over-year growth 2024-2029 (%)
  • Exhibits81: Data Table on Hospital and clinics - Year-over-year growth 2024-2029 (%)
  • Exhibits82: Chart on Diagnostic centers - Market size and forecast 2024-2029 ($ million)
  • Exhibits83: Data Table on Diagnostic centers - Market size and forecast 2024-2029 ($ million)
  • Exhibits84: Chart on Diagnostic centers - Year-over-year growth 2024-2029 (%)
  • Exhibits85: Data Table on Diagnostic centers - Year-over-year growth 2024-2029 (%)
  • Exhibits86: Chart on Individuals - Market size and forecast 2024-2029 ($ million)
  • Exhibits87: Data Table on Individuals - Market size and forecast 2024-2029 ($ million)
  • Exhibits88: Chart on Individuals - Year-over-year growth 2024-2029 (%)
  • Exhibits89: Data Table on Individuals - Year-over-year growth 2024-2029 (%)
  • Exhibits90: Market opportunity by End-user ($ million)
  • Exhibits91: Data Table on Market opportunity by End-user ($ million)
  • Exhibits92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits93: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits94: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits95: Chart on Geographic comparison
  • Exhibits96: Data Table on Geographic comparison
  • Exhibits97: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits98: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits99: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits100: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits101: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits102: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits103: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits104: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits105: Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits106: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits107: Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits108: Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits109: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits110: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits111: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits112: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits113: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits114: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits116: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits118: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits120: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits122: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits124: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits126: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits127: Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits128: Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits129: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits130: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits131: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits132: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits133: Chart on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits134: Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits135: Chart on France - Year-over-year growth 2024-2029 (%)
  • Exhibits136: Data Table on France - Year-over-year growth 2024-2029 (%)
  • Exhibits137: Chart on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits138: Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits139: Chart on India - Year-over-year growth 2024-2029 (%)
  • Exhibits140: Data Table on India - Year-over-year growth 2024-2029 (%)
  • Exhibits141: Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits142: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits143: Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits144: Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits145: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits146: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits147: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits148: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits149: Chart on Spain - Market size and forecast 2024-2029 ($ million)
  • Exhibits150: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
  • Exhibits151: Chart on Spain - Year-over-year growth 2024-2029 (%)
  • Exhibits152: Data Table on Spain - Year-over-year growth 2024-2029 (%)
  • Exhibits153: Market opportunity By Geographical Landscape ($ million)
  • Exhibits154: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits155: Impact of drivers and challenges in 2024 and 2029
  • Exhibits156: Overview on criticality of inputs and factors of differentiation
  • Exhibits157: Overview on factors of disruption
  • Exhibits158: Impact of key risks on business
  • Exhibits159: Companies covered
  • Exhibits160: Company ranking index
  • Exhibits161: Matrix on companies position and classification
  • Exhibits162: Aurobindo Pharma Ltd. - Overview
  • Exhibits163: Aurobindo Pharma Ltd. - Product / Service
  • Exhibits164: Aurobindo Pharma Ltd. - Key offerings
  • Exhibits165: SWOT
  • Exhibits166: Becton Dickinson and Co. - Overview
  • Exhibits167: Becton Dickinson and Co. - Business segments
  • Exhibits168: Becton Dickinson and Co. - Key news
  • Exhibits169: Becton Dickinson and Co. - Key offerings
  • Exhibits170: Becton Dickinson and Co. - Segment focus
  • Exhibits171: SWOT
  • Exhibits172: Cepheid Inc. - Overview
  • Exhibits173: Cepheid Inc. - Product / Service
  • Exhibits174: Cepheid Inc. - Key offerings
  • Exhibits175: SWOT
  • Exhibits176: DiaSorin SpA - Overview
  • Exhibits177: DiaSorin SpA - Business segments
  • Exhibits178: DiaSorin SpA - Key news
  • Exhibits179: DiaSorin SpA - Key offerings
  • Exhibits180: DiaSorin SpA - Segment focus
  • Exhibits181: SWOT
  • Exhibits182: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits183: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits184: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits185: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits186: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits187: SWOT
  • Exhibits188: Gilead Sciences Inc. - Overview
  • Exhibits189: Gilead Sciences Inc. - Product / Service
  • Exhibits190: Gilead Sciences Inc. - Key news
  • Exhibits191: Gilead Sciences Inc. - Key offerings
  • Exhibits192: SWOT
  • Exhibits193: GlaxoSmithKline Plc - Overview
  • Exhibits194: GlaxoSmithKline Plc - Business segments
  • Exhibits195: GlaxoSmithKline Plc - Key news
  • Exhibits196: GlaxoSmithKline Plc - Key offerings
  • Exhibits197: GlaxoSmithKline Plc - Segment focus
  • Exhibits198: SWOT
  • Exhibits199: Hologic Inc. - Overview
  • Exhibits200: Hologic Inc. - Business segments
  • Exhibits201: Hologic Inc. - Key news
  • Exhibits202: Hologic Inc. - Key offerings
  • Exhibits203: Hologic Inc. - Segment focus
  • Exhibits204: SWOT
  • Exhibits205: Inovio Pharmaceuticals Inc. - Overview
  • Exhibits206: Inovio Pharmaceuticals Inc. - Product / Service
  • Exhibits207: Inovio Pharmaceuticals Inc. - Key news
  • Exhibits208: Inovio Pharmaceuticals Inc. - Key offerings
  • Exhibits209: SWOT
  • Exhibits210: Johnson and Johnson Services Inc. - Overview
  • Exhibits211: Johnson and Johnson Services Inc. - Business segments
  • Exhibits212: Johnson and Johnson Services Inc. - Key news
  • Exhibits213: Johnson and Johnson Services Inc. - Key offerings
  • Exhibits214: Johnson and Johnson Services Inc. - Segment focus
  • Exhibits215: SWOT
  • Exhibits216: Lupin Ltd. - Overview
  • Exhibits217: Lupin Ltd. - Business segments
  • Exhibits218: Lupin Ltd. - Key news
  • Exhibits219: Lupin Ltd. - Key offerings
  • Exhibits220: Lupin Ltd. - Segment focus
  • Exhibits221: SWOT
  • Exhibits222: Merck and Co. Inc. - Overview
  • Exhibits223: Merck and Co. Inc. - Business segments
  • Exhibits224: Merck and Co. Inc. - Key news
  • Exhibits225: Merck and Co. Inc. - Key offerings
  • Exhibits226: Merck and Co. Inc. - Segment focus
  • Exhibits227: SWOT
  • Exhibits228: Mission Pharmacal Co. - Overview
  • Exhibits229: Mission Pharmacal Co. - Product / Service
  • Exhibits230: Mission Pharmacal Co. - Key offerings
  • Exhibits231: SWOT
  • Exhibits232: Mylan - Overview
  • Exhibits233: Mylan - Product / Service
  • Exhibits234: Mylan - Key offerings
  • Exhibits235: SWOT
  • Exhibits236: Thermo Fisher Scientific Inc. - Overview
  • Exhibits237: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits238: Thermo Fisher Scientific Inc. - Key news
  • Exhibits239: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits240: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits241: SWOT
  • Exhibits242: Inclusions checklist
  • Exhibits243: Exclusions checklist
  • Exhibits244: Currency conversion rates for US$
  • Exhibits245: Research methodology
  • Exhibits246: Information sources
  • Exhibits247: Data validation
  • Exhibits248: Validation techniques employed for market sizing
  • Exhibits249: Data synthesis
  • Exhibits250: 360 degree market analysis
  • Exhibits251: List of abbreviations
目次
Product Code: IRTNTR74264

The sexually transmitted diseases (STD) treatment market is forecasted to grow by USD 24,205.2 mn during 2024-2029, accelerating at a CAGR of 7% during the forecast period. The report on the sexually transmitted diseases (STD) treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of stds, presence of favorable reimbursement policies treatment coverage for stds, and increased initiatives by governments worldwide.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20256.5%
CAGR7%
Incremental Value$24,205.2 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's sexually transmitted diseases (STD) treatment market is segmented as below:

By Type

    • Viral infections
    • Bacterial infections
    • Others

By Route Of Administration

    • Oral
    • Topical
    • Injectable

By End-user

    • Hospital and clinics
    • Diagnostic centers
    • Individuals

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the advances in rapid diagnosis of stds as one of the prime reasons driving the sexually transmitted diseases (STD) treatment market growth during the next few years. Also, increasing involvement of various organizations to create awareness about stds and growing adoption of ept will lead to sizable demand in the market.

The report on the sexually transmitted diseases (STD) treatment market covers the following areas:

    • Sexually Transmitted Diseases (STD) Treatment Market sizing
    • Sexually Transmitted Diseases (STD) Treatment Market forecast
    • Sexually Transmitted Diseases (STD) Treatment Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sexually transmitted diseases (STD) treatment market vendors that include Aurobindo Pharma Ltd., Becton Dickinson and Co., Cepheid Inc., DiaSorin SpA, F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Hologic Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson Services Inc., Lupin Ltd., Merck and Co. Inc., Mission Pharmacal Co., Mylan, and Thermo Fisher Scientific Inc.. Also, the sexually transmitted diseases (STD) treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Market Segmentation by Route of Administration
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Sexually Transmitted Diseases (STD) Treatment Market 2019 - 2023
    • Historic Market Size - Data Table on Global Sexually Transmitted Diseases (STD) Treatment Market 2019 - 2023 ($ million)
  • 5.2 Type segment analysis 2019 - 2023
    • Historic Market Size - Type Segment 2019 - 2023 ($ million)
  • 5.3 Route of Administration segment analysis 2019 - 2023
    • Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
  • 5.4 End-user segment analysis 2019 - 2023
    • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 The AI impact on Global Sexually Transmitted Diseases (STD) Treatment Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Type

  • 8.1 Market segments
    • Chart on Type - Market share 2024-2029 (%)
    • Data Table on Type - Market share 2024-2029 (%)
  • 8.2 Comparison by Type
    • Chart on Comparison by Type
    • Data Table on Comparison by Type
  • 8.3 Viral infections - Market size and forecast 2024-2029
    • Chart on Viral infections - Market size and forecast 2024-2029 ($ million)
    • Data Table on Viral infections - Market size and forecast 2024-2029 ($ million)
    • Chart on Viral infections - Year-over-year growth 2024-2029 (%)
    • Data Table on Viral infections - Year-over-year growth 2024-2029 (%)
  • 8.4 Bacterial infections - Market size and forecast 2024-2029
    • Chart on Bacterial infections - Market size and forecast 2024-2029 ($ million)
    • Data Table on Bacterial infections - Market size and forecast 2024-2029 ($ million)
    • Chart on Bacterial infections - Year-over-year growth 2024-2029 (%)
    • Data Table on Bacterial infections - Year-over-year growth 2024-2029 (%)
  • 8.5 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ million)
    • Data Table on Others - Market size and forecast 2024-2029 ($ million)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 8.6 Market opportunity by Type
    • Market opportunity by Type ($ million)
    • Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by Route of Administration

  • 9.1 Market segments
    • Chart on Route of Administration - Market share 2024-2029 (%)
    • Data Table on Route of Administration - Market share 2024-2029 (%)
  • 9.2 Comparison by Route of Administration
    • Chart on Comparison by Route of Administration
    • Data Table on Comparison by Route of Administration
  • 9.3 Oral - Market size and forecast 2024-2029
    • Chart on Oral - Market size and forecast 2024-2029 ($ million)
    • Data Table on Oral - Market size and forecast 2024-2029 ($ million)
    • Chart on Oral - Year-over-year growth 2024-2029 (%)
    • Data Table on Oral - Year-over-year growth 2024-2029 (%)
  • 9.4 Topical - Market size and forecast 2024-2029
    • Chart on Topical - Market size and forecast 2024-2029 ($ million)
    • Data Table on Topical - Market size and forecast 2024-2029 ($ million)
    • Chart on Topical - Year-over-year growth 2024-2029 (%)
    • Data Table on Topical - Year-over-year growth 2024-2029 (%)
  • 9.5 Injectable - Market size and forecast 2024-2029
    • Chart on Injectable - Market size and forecast 2024-2029 ($ million)
    • Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
    • Chart on Injectable - Year-over-year growth 2024-2029 (%)
    • Data Table on Injectable - Year-over-year growth 2024-2029 (%)
  • 9.6 Market opportunity by Route of Administration
    • Market opportunity by Route of Administration ($ million)
    • Data Table on Market opportunity by Route of Administration ($ million)

10 Market Segmentation by End-user

  • 10.1 Market segments
    • Chart on End-user - Market share 2024-2029 (%)
    • Data Table on End-user - Market share 2024-2029 (%)
  • 10.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 10.3 Hospital and clinics - Market size and forecast 2024-2029
    • Chart on Hospital and clinics - Market size and forecast 2024-2029 ($ million)
    • Data Table on Hospital and clinics - Market size and forecast 2024-2029 ($ million)
    • Chart on Hospital and clinics - Year-over-year growth 2024-2029 (%)
    • Data Table on Hospital and clinics - Year-over-year growth 2024-2029 (%)
  • 10.4 Diagnostic centers - Market size and forecast 2024-2029
    • Chart on Diagnostic centers - Market size and forecast 2024-2029 ($ million)
    • Data Table on Diagnostic centers - Market size and forecast 2024-2029 ($ million)
    • Chart on Diagnostic centers - Year-over-year growth 2024-2029 (%)
    • Data Table on Diagnostic centers - Year-over-year growth 2024-2029 (%)
  • 10.5 Individuals - Market size and forecast 2024-2029
    • Chart on Individuals - Market size and forecast 2024-2029 ($ million)
    • Data Table on Individuals - Market size and forecast 2024-2029 ($ million)
    • Chart on Individuals - Year-over-year growth 2024-2029 (%)
    • Data Table on Individuals - Year-over-year growth 2024-2029 (%)
  • 10.6 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 12.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.8 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.9 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.10 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 12.11 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.12 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 12.13 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ million)
    • Data Table on India - Market size and forecast 2024-2029 ($ million)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 12.14 Italy - Market size and forecast 2024-2029
    • Chart on Italy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
    • Chart on Italy - Year-over-year growth 2024-2029 (%)
    • Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • 12.15 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 12.16 Spain - Market size and forecast 2024-2029
    • Chart on Spain - Market size and forecast 2024-2029 ($ million)
    • Data Table on Spain - Market size and forecast 2024-2029 ($ million)
    • Chart on Spain - Year-over-year growth 2024-2029 (%)
    • Data Table on Spain - Year-over-year growth 2024-2029 (%)
  • 12.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Aurobindo Pharma Ltd.
    • Aurobindo Pharma Ltd. - Overview
    • Aurobindo Pharma Ltd. - Product / Service
    • Aurobindo Pharma Ltd. - Key offerings
    • SWOT
  • 15.5 Becton Dickinson and Co.
    • Becton Dickinson and Co. - Overview
    • Becton Dickinson and Co. - Business segments
    • Becton Dickinson and Co. - Key news
    • Becton Dickinson and Co. - Key offerings
    • Becton Dickinson and Co. - Segment focus
    • SWOT
  • 15.6 Cepheid Inc.
    • Cepheid Inc. - Overview
    • Cepheid Inc. - Product / Service
    • Cepheid Inc. - Key offerings
    • SWOT
  • 15.7 DiaSorin SpA
    • DiaSorin SpA - Overview
    • DiaSorin SpA - Business segments
    • DiaSorin SpA - Key news
    • DiaSorin SpA - Key offerings
    • DiaSorin SpA - Segment focus
    • SWOT
  • 15.8 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 15.9 Gilead Sciences Inc.
    • Gilead Sciences Inc. - Overview
    • Gilead Sciences Inc. - Product / Service
    • Gilead Sciences Inc. - Key news
    • Gilead Sciences Inc. - Key offerings
    • SWOT
  • 15.10 GlaxoSmithKline Plc
    • GlaxoSmithKline Plc - Overview
    • GlaxoSmithKline Plc - Business segments
    • GlaxoSmithKline Plc - Key news
    • GlaxoSmithKline Plc - Key offerings
    • GlaxoSmithKline Plc - Segment focus
    • SWOT
  • 15.11 Hologic Inc.
    • Hologic Inc. - Overview
    • Hologic Inc. - Business segments
    • Hologic Inc. - Key news
    • Hologic Inc. - Key offerings
    • Hologic Inc. - Segment focus
    • SWOT
  • 15.12 Inovio Pharmaceuticals Inc.
    • Inovio Pharmaceuticals Inc. - Overview
    • Inovio Pharmaceuticals Inc. - Product / Service
    • Inovio Pharmaceuticals Inc. - Key news
    • Inovio Pharmaceuticals Inc. - Key offerings
    • SWOT
  • 15.13 Johnson and Johnson Services Inc.
    • Johnson and Johnson Services Inc. - Overview
    • Johnson and Johnson Services Inc. - Business segments
    • Johnson and Johnson Services Inc. - Key news
    • Johnson and Johnson Services Inc. - Key offerings
    • Johnson and Johnson Services Inc. - Segment focus
    • SWOT
  • 15.14 Lupin Ltd.
    • Lupin Ltd. - Overview
    • Lupin Ltd. - Business segments
    • Lupin Ltd. - Key news
    • Lupin Ltd. - Key offerings
    • Lupin Ltd. - Segment focus
    • SWOT
  • 15.15 Merck and Co. Inc.
    • Merck and Co. Inc. - Overview
    • Merck and Co. Inc. - Business segments
    • Merck and Co. Inc. - Key news
    • Merck and Co. Inc. - Key offerings
    • Merck and Co. Inc. - Segment focus
    • SWOT
  • 15.16 Mission Pharmacal Co.
    • Mission Pharmacal Co. - Overview
    • Mission Pharmacal Co. - Product / Service
    • Mission Pharmacal Co. - Key offerings
    • SWOT
  • 15.17 Mylan
    • Mylan - Overview
    • Mylan - Product / Service
    • Mylan - Key offerings
    • SWOT
  • 15.18 Thermo Fisher Scientific Inc.
    • Thermo Fisher Scientific Inc. - Overview
    • Thermo Fisher Scientific Inc. - Business segments
    • Thermo Fisher Scientific Inc. - Key news
    • Thermo Fisher Scientific Inc. - Key offerings
    • Thermo Fisher Scientific Inc. - Segment focus
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations